Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01237691 · ClinicalTrials.gov registry record · NA
An Evaluation of California's Experiment With HOPE
A NA study, sponsored by Pepperdine University.
- Completed
- Registry status
- NA
- Development phase
- 105
- Enrollment target
NCT01237691 is a NA study that has completed, run by Pepperdine University. The registered enrollment target is 105 participants.
The verdict
NCT01237691, a NA study, has completed, sponsored by Pepperdine University.
- COMPLETED
- Registry status
- NA
- Development phase
- 105 participants
- Enrollment target
Study Summary
The phase I evaluation is intended to assess whether or not frequent drug testing and immediate short-term incarceration for drug use and/or other violations and mandated drug treatment for multiple violations, reduces the recurrence of drug use and/or other violation behaviors by California parolees assigned to the study group.
Interventions
- BEHAVIORAL HOPE supervision
- BEHAVIORAL Parole-as-usual
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2010-11 |
| Est. Completion | 2013-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01237691
The ClinicalTrials.gov registry entry for NCT01237691 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pepperdine University, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which HOPE supervision is the first listed.
NCT01237691 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01237691 about?
NCT01237691 is a clinical study titled "An Evaluation of California's Experiment With HOPE". The phase I evaluation is intended to assess whether or not frequent drug testing and immediate short-term incarceration for drug use and/or other violations and mandated drug treatment for multiple violations, reduces the recurrence of drug use and/or other violation behaviors by California parolee...
What is the current status of trial NCT01237691?
This trial is currently completed. It is a NA study. The enrollment target is 105 participants. The study started on 2010-11. Estimated completion is 2013-03.
What interventions are being tested in trial NCT01237691?
The interventions under investigation include: HOPE supervision (BEHAVIORAL), Parole-as-usual (BEHAVIORAL).
Who is sponsoring clinical trial NCT01237691?
This trial is sponsored by Pepperdine University, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.